Skip to main content
Clinical Trials/NCT03334864
NCT03334864RecruitingNot Applicable

Observational Cohort Study of Advanced Non-small Cell Lung Cancer (CAPTRA-LUNG)

Peking Union Medical College Hospital1 site in 1 country5,000 target enrollmentStarted: November 3, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
5,000
Locations
1
Primary Endpoint
Overall Survival (OS)

Study Overview

Brief Summary

Investigators propose to establish and maintain a cohort of patients with advanced non-small cell lung cancer, and to assess the treatment pattern, host genetic, and clinical factors which influence the prognosis and survival, as well as the interaction among these factors on disease diagnosis and treatment, short and long-term outcomes.

Study type: Observational (Patient Registry)

Study design: Observational Model: Cohort

Time Perspective: Prospective and retrospective

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Other

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Cohort I: diagnosis of advanced non-small cell lung cancer from 2012-2016;
  • Cohort II: documented positive driver gene mutations; and diagnosis of advanced non-small cell lung cancer;
  • Cohort III: diagnosis of advanced non-small cell lung cancer and in immune-therapy;
  • Cohort IV: diagnosis of advanced non-small cell lung cancer, and with wild-type driver gene or unknown driver gene status;
  • Cohort V: treated with anti-VEGF drug in first line, diagnosis of advanced non-squamous and non-small cell lung cancer in 6 months before recruit;
  • Age>18 years;
  • Provision of written informed consent.

Exclusion Criteria

  • not applicable

Outcomes

Primary Outcomes

Overall Survival (OS)

Time Frame: 3 years

OS was calculated from the diagnosis of advanced non-small cell lung cancer to death from any reasons

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials